Home  /  Resource Library  /  Real-world evidence for pembrolizumab gemcitabine vinorelbine and liposomal doxorubicin in classical Hodgkin lymphoma

Real-world evidence for pembrolizumab gemcitabine vinorelbine and liposomal doxorubicin in classical Hodgkin lymphoma

Real world study investigating pembrolizumab combined with chemotherapy for Hodgkin lymphoma.